Comparison of dexmedetomidine and midazolam sedation and antagonism of dexmedetomidine with atipamezole
- 30 June 1993
- journal article
- clinical trial
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 5 (3) , 194-203
- https://doi.org/10.1016/0952-8180(93)90014-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The Effect of Intravenously Administered Dexmedetomidine on Perioperative Hemodynamics and Isoflurane Requirements in Patients Undergoing Abdominal HysterectomyAnesthesiology, 1991
- REVERSAL OF BENZODIAZEPINE SEDATION WITH THE ANTAGONIST FLUMAZENILBritish Journal of Anaesthesia, 1991
- Central α2-adrenoceptors are highly stereoselective for dexmedetomidine, the dextro enantiomer of medetomidineEuropean Journal of Pharmacology, 1991
- Dexmedetomidine, an α2-Adrenoceptor Agonist, Reduces Anesthetic Requirements for Patients Undergoing Minor Gynecologic SurgeryAnesthesiology, 1990
- Pharmacological effects and pharmacokinetics of atipamezole, a novel alpha 2‐adrenoceptor antagonist‐a randomized, double‐blind cross‐over study in healthy male volunteers.British Journal of Clinical Pharmacology, 1990
- Induction agents for day‐case anaesthesia A double‐blind comparison of propofol and midazolam antagonised by flumazenilAnaesthesia, 1990
- Effects of dexmedetomidine, a selective α2-adrenoceptor agonist, on hemodynamic control mechanismsClinical Pharmacology & Therapeutics, 1989
- Time Course of Antagonism of Sedative and Amnesic Effects of Diazepam by FlumazenilAnesthesiology, 1989
- Flumazenil used for antagonizing the central effects of midazolam and diazepam in outpatientsActa Anaesthesiologica Scandinavica, 1989
- Characterization of the selectivity, specificity and potency of medetomidine as an α2-adrenoceptor agonistEuropean Journal of Pharmacology, 1988